BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38098215)

  • 21. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis.
    Ros P; Rossi DL; Acebrón A; Santisteban P
    Biochimie; 1999 Apr; 81(4):389-96. PubMed ID: 10401674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment.
    Feng F; Wang H; Fu H; Wu S; Ye Z; Chen S; Li J
    Nucl Med Biol; 2011 Oct; 38(7):1053-8. PubMed ID: 21982575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.
    Arturi F; Russo D; Bidart JM; Scarpelli D; Schlumberger M; Filetti S
    Eur J Endocrinol; 2001 Aug; 145(2):129-35. PubMed ID: 11454507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of pendrin in benign and malignant human thyroid tissues.
    Skubis-Zegadło J; Nikodemska A; Przytuła E; Mikula M; Bardadin K; Ostrowski J; Wenzel BE; Czarnocka B
    Br J Cancer; 2005 Jul; 93(1):144-51. PubMed ID: 15942636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyrotropin, but Not Thyroid-Stimulating Antibodies, Induces Biphasic Regulation of Gene Expression in Human Thyrocytes.
    Jang D; Morgan SJ; Klubo-Gwiezdzinska J; Banga JP; Neumann S; Gershengorn MC
    Thyroid; 2020 Feb; 30(2):270-276. PubMed ID: 31805824
    [No Abstract]   [Full Text] [Related]  

  • 26. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.
    Bizhanova A; Kopp P
    Endocrinology; 2009 Mar; 150(3):1084-90. PubMed ID: 19196800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimally invasive follicular thyroid cancer: treat as a benign or malignant lesion?
    Robinson A; Schneider D; Sippel R; Chen H
    J Surg Res; 2017 Jan; 207():235-240. PubMed ID: 27979483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D in thyroid tumorigenesis and development.
    Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
    Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms.
    Fabbro D; Di Loreto C; Beltrami CA; Belfiore A; Di Lauro R; Damante G
    Cancer Res; 1994 Sep; 54(17):4744-9. PubMed ID: 8062273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
    Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin enhances the membrane trafficking of the sodium iodide symporter and augments radioiodine uptake in dedifferentiated thyroid cancer cells
    Zhang L; Xu S; Cheng X; Wu J; Wang X; Wu L; Yu H; Bao J
    Food Funct; 2021 Sep; 12(18):8260-8273. PubMed ID: 34323243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma.
    Poma AM; Giannini R; Piaggi P; Ugolini C; Materazzi G; Miccoli P; Vitti P; Basolo F
    Endocr Connect; 2018 Jan; 7(1):124-132. PubMed ID: 29298844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma.
    Mirebeau-Prunier D; Guyétant S; Rodien P; Franc B; Baris O; Rohmer V; Reynier P; Tourmen Y; Malthièry Y; Savagner F
    Eur J Endocrinol; 2004 Mar; 150(3):269-76. PubMed ID: 15012610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene.
    Suzuki K; Mori A; Saito J; Moriyama E; Ullianich L; Kohn LD
    Endocrinology; 1999 Nov; 140(11):5422-30. PubMed ID: 10537174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-induction of cell differentiation and (131)I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection.
    Feng F; Wang H; Hou S; Fu H
    Nucl Med Biol; 2012 Nov; 39(8):1261-5. PubMed ID: 22898315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.
    Jung YH; Hah JH; Sung MW; Kim KH; Cho SY; Jeon YK
    Laryngoscope; 2009 Mar; 119(3):541-8. PubMed ID: 19235753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium iodide symporter and pendrin expression in human thyroid tissues.
    Mian C; Lacroix L; Alzieu L; Nocera M; Talbot M; Bidart JM; Schlumberger M; Caillou B
    Thyroid; 2001 Sep; 11(9):825-30. PubMed ID: 11575851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing.
    Kleiman DA; Buitrago D; Crowley MJ; Beninato T; Veach AJ; Zanzonico PB; Jin M; Fahey TJ; Zarnegar R
    J Surg Res; 2013 Jun; 182(1):85-93. PubMed ID: 22998776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Value of Sonography in Distinguishing Follicular Thyroid Carcinoma from Adenoma.
    Li W; Song Q; Lan Y; Li J; Zhang Y; Yan L; Li Y; Zhang Y; Luo Y
    Cancer Manag Res; 2021; 13():3991-4002. PubMed ID: 34040440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.